1,171 research outputs found

    Functions and Requirements of the CMS Centre at CERN

    Get PDF
    This report of the CMS Centre Requirements and Technical Assessment Group describes the functions of the CMS Centre on the CERN Meyrin site in terms of data quality monitoring, calibrations and rapid analysis and operations of the offline computing systems. It then defines the corresponding requirements for building space, computing consoles and other equipment, technical services and refurbishments, and communications systems

    An automated in vitro model for the evaluation of ultrasound modalities measuring myocardial deformation

    Get PDF
    <p>Abstract</p> <p>Background</p> <p>Echocardiography is the method of choice when one wishes to examine myocardial function. Qualitative assessment of the 2D grey scale images obtained is subjective, and objective methods are required. Speckle Tracking Ultrasound is an emerging technology, offering an objective mean of quantifying left ventricular wall motion. However, before a new ultrasound technology can be adopted in the clinic, accuracy and reproducibility needs to be investigated.</p> <p>Aim</p> <p>It was hypothesized that the collection of ultrasound sample data from an in vitro model could be automated. The aim was to optimize an in vitro model to allow for efficient collection of sample data.</p> <p>Material & Methods</p> <p>A tissue-mimicking phantom was made from water, gelatin powder, psyllium fibers and a preservative. Sonomicrometry crystals were molded into the phantom. The solid phantom was mounted in a stable stand and cyclically compressed. Peak strain was then measured by Speckle Tracking Ultrasound and sonomicrometry.</p> <p>Results</p> <p>We succeeded in automating the acquisition and analysis of sample data. Sample data was collected at a rate of 200 measurement pairs in 30 minutes. We found good agreement between Speckle Tracking Ultrasound and sonomicrometry in the in vitro model. Best agreement was 0.83 ± 0.70%. Worst agreement was -1.13 ± 6.46%.</p> <p>Conclusions</p> <p>It has been shown possible to automate a model that can be used for evaluating the in vitro accuracy and precision of ultrasound modalities measuring deformation. Sonomicrometry and Speckle Tracking Ultrasound had acceptable agreement.</p

    Concerted measurements of lipids in seawater and on submicron aerosol particles at the Cape Verde Islands: biogenic sources, selective transfer and high enrichments

    Get PDF
    Measurements of lipids as representative species for different lipid classes in the marine environment have been performed to characterize their oceanic sources and their transfer from the ocean into the atmosphere to marine aerosol particles. To this end, a set of lipid classes (hydrocarbons (HC), fatty acid methyl esters (ME), free fatty acids (FFA), alcohols (ALC), 1, 3-diacylglycerols (1, 3 DG), 1, 2-diacylglycerols (1, 2 DG), monoacylglycerols (MG), wax esters (WE), triacylglycerols (TG), phospholipids (PP) including phosphatidylglycerols (PG), phosphatidylethanolamine (PE), phosphatidylcholines (PC), glycolipids (GL) including sulfoquinovosyldiacylglycerols (SQDG), monogalactosyl-diacylglycerols (MGDG), digalactosyldiacylglycerols (DGDG) and sterols (ST)) is investigated in both the dissolved and particulate fraction in seawater, differentiated between underlying water (ULW) and the sea surface microlayer (SML), and in ambient submicron aerosol particle samples (PM1) at the Cape Verde Atmospheric Observatory (CVAO) applying concerted measurements. The different lipids are found in all marine compartments but in different compositions. At this point, a certain variability is observed for the concentration of dissolved (∑DLULW: 39.8–128.5 μg L−1, ∑DLSML: 55.7–121.5 μg L−1) and particulate (∑PLULW: 36.4–93.5 μg L−1, ∑PLSML: 61.0–118.1 μg L−1) lipids in seawater of the tropical North Atlantic Ocean along the campaign. Only slight SML enrichments are observed for the lipids with an enrichment factor EFSML of 1.1–1.4 (DL) and 1.0–1.7 (PL). On PM1 aerosol particles, a total lipid concentration between 75.2–219.5 ng m−3 (averaged: 119.9 ng m−3) is measured with high atmospheric concentration of TG (averaged: 21.9 ng m−3) as a potential indicator for freshly emitted sea spray. Besides phytoplankton sources, bacteria influence the lipid concentrations in seawater and on the aerosol particles, so that the phytoplankton tracer (chlorophyll-a) cannot sufficiently explain the lipid abundance. The concentration and enrichment of lipids in the SML is not related to physicochemical properties describing the surface activity. For aerosol, however, the high enrichment of lipids (as a sum) corresponds well with the consideration of their high surface activity, thus the EFaer (enrichment factor on submicron aerosol particles compared to SML) ranges between 9 × 104–7 × 105. Regarding the single lipid groups on the aerosol particles, a weak relation between EFaer and lipophilicity (expressed by the KOW value) was identified, which was absent for the SML. However, overall simple physico- chemical descriptors are not sufficient to fully explain the transfer of lipids. As our findings show that additional processes such as formation and degradation influence the ocean- atmosphere transfer of both OM in general and of lipids in particular, they have to be considered in OM transfer models. Moreover, our data suggest that the extend of enrichment of lipid classes constituents on the aerosol particles might be related to the distribution of the lipid within the bubble-air-water- interface. Lipids, which are preferably arranged within the bubble interface, namely TG and ALC, are transferred to the aerosol particles to the highest extend. Finally, the connection between ice nucleation particles (INP) in seawater, which are active already at higher temperatures (−10 °C to −15 °C), and the lipid classes PE and FFA suggests that lipids formed in the ocean have the potential to contribute to (biogenic) INP activity when transferred to the atmosphere

    Tyrosine hydroxylase deficiency: a treatable disorder of brain catecholamine biosynthesis

    Get PDF
    Tyrosine hydroxylase deficiency is an autosomal recessive disorder resulting from cerebral catecholamine deficiency. Tyrosine hydroxylase deficiency has been reported in fewer than 40 patients worldwide. To recapitulate all available evidence on clinical phenotypes and rational diagnostic and therapeutic approaches for this devastating, but treatable, neurometabolic disorder, we studied 36 patients with tyrosine hydroxylase deficiency and reviewed the literature. Based on the presenting neurological features, tyrosine hydroxylase deficiency can be divided in two phenotypes: an infantile onset, progressive, hypokinetic-rigid syndrome with dystonia (type A), and a complex encephalopathy with neonatal onset (type B). Decreased cerebrospinal fluid concentrations of homovanillic acid and 3-methoxy-4-hydroxyphenylethylene glycol, with normal 5-hydroxyindoleacetic acid cerebrospinal fluid concentrations, are the biochemical hallmark of tyrosine hydroxylase deficiency. The homovanillic acid concentrations and homovanillic acid/5-hydroxyindoleacetic acid ratio in cerebrospinal fluid correlate with the severity of the phenotype. Tyrosine hydroxylase deficiency is almost exclusively caused by missense mutations in the TH gene and its promoter region, suggesting that mutations with more deleterious effects on the protein are incompatible with life. Genotype-phenotype correlations do not exist for the common c.698G>A and c.707T>C mutations. Carriership of at least one promotor mutation, however, apparently predicts type A tyrosine hydroxylase deficiency. Most patients with tyrosine hydroxylase deficiency can be successfully treated with l-dop
    corecore